Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Evrysdi


Contraindicated
Reproductive toxicity in animals

Contraindicated
Lack of data
Evrysdi :
Type Medicine Authorised
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory Roche
Responsible Party F. Hoffmann La Roche Ltd
Origin Switzerland
Manufacturer F. Hoffmann La Roche Ltd
Origin Switzerland
ATC M09AX10

Your comment will appear shortly after approval

Evrysdi :

Revision Date : 04/05/2021


Effect Frequency
Aphthous ulcer Common
Arthralgia (Pain joint) (Joint ache) Common
Diarrhoea (Diarrhea) Very Common
Headache Very Common
Mouth ulceration Common
Nausea Common
Pyrexia Very Common
Skin rash Very Common
Urinary tract infection Common

Different Units By MoH Code

Evrysdi  MoH 12038 :
Form Powder for oral solution
Packaging Vial (Type III Glass)
Package Size 80ml
Strength 0.75mg/ml
Public Price 865644066.76 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 20722/1
Submission date 02/07/2022
Registration Year 26/03/2025


Price Comparison

● Country: Lebanon
● Form: Powder for oral solution
● Package Size: 80ml
● Pack size unit used: 80
● Cost/Unit: 10820550.83 LBP ( 10,820,550.83 LBP )
● Pricing Date: 11/08/2026

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

5q Spinal muscular atrophy (SMA) : (Infants)
● Cost/Unit: 10820550.83 LBP ( 10,820,550.83 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
5q Spinal muscular atrophy (SMA) : (Young Children)
● Cost/Unit: 10820550.83 LBP ( 10,820,550.83 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info